Galectin 3 Antibody (Rabbit mAb) [K11P7]

CatNo: F7944

    Application: Reactivity:
    • Lane 1: A375, Lane 2: HeLa, Lane 3: A431, Lane 4: RAW264.7
    1/
    サイズ 価格(税別) 在庫状況
    JPY 17900 国内在庫なし(納期7~10日)
    JPY 38900 国内在庫なし(納期7~10日)
    JPY 58400 お問い合わせ

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp
    よく尋ねられる質問

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min
    推奨WB希釈率: 1:10000

    使用情報

    Dilution
    1:5000 - 1:10000
    1:250
    1:1000
    1:50
    Application
    WB, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    26 kDa 30 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Mouse lung tissue; Human lung squamous carcinoma tissue; Human thyroid carcinoma tissue; Mouse liver tissue; Human liver tissue; Rat colon tissue; Panc-1 cells; A375 cells; C6 cells; RAW264.7 cells; NIH/3T3 cells; A431 cells; HT-29 cells; THP1 cells; SW480 cells; A549 cells; MCF7 cells; HeLa cells
    ネガティブコントロール Mouse brain tissue; Neuro-2a cells; SK-N-MC cells; LNCaP cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:10000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Galectin 3 Antibody (Rabbit mAb) [K11P7] detects endogenous levels of total Galectin 3 protein.
    タンパク質の局在
    細胞質、細胞核、細胞外環境、スプライソソーム
    Uniprot ID
    P17931
    Clone
    K11P7
    Synonym(s)
    35 kDa lectin | advanced glycation end-product receptor 3 | Carbohydrate-binding protein 35 | CBP 35 | CBP35 | epididymis secretory sperm binding protein | Gal-3 | GAL3 | Galactose-specific lectin 3 | Galactoside-binding protein | GALBP | galectin 3 | Galectin-3 | GALIG | IgE-binding protein | L-31 | L31 | Laminin-binding protein | Lectin L-29 | lectin | galactoside-binding | soluble | 3 | LEG3 | LGALS2 | LGALS3 | Mac-2 antigen | MAC2
    Background
    Galectin‑3 (LGALS3) is a chimera-type β‑galactoside-binding lectin within the galectin family that carries a C‑terminal carbohydrate-recognition domain (CRD) and an N‑terminal proline- and glycine-rich region mediating oligomerization, and it regulates cell–cell and cell–matrix interactions, growth, differentiation and inflammatory responses across multiple tissues including heart, liver, kidney and gastrointestinal tract. The CRD binds N‑acetyllactosamine-containing glycoconjugates on glycoproteins and extracellular matrix components, while the N‑terminal tail supports multimer formation, allowing galectin‑3 to form lattice-like structures at the cell surface that control receptor clustering, endocytosis and signaling thresholds for growth factor and immune receptors. Intracellularly, galectin‑3 interacts with anti-apoptotic proteins such as Bcl‑2 and influences mitochondrial and nuclear pathways that regulate apoptosis and cell survival, whereas extracellular galectin‑3, secreted via non-classical pathways, binds integrins, laminin and other matrix molecules to modulate adhesion, migration and angiogenesis, illustrating compartment-specific mechanisms that together shape tissue remodeling and host responses. In immune regulation, galectin‑3 organizes microenvironments that drive inflammation and innate and adaptive immune responses; it induces monocyte–macrophage differentiation, affects dendritic cell fate, regulates T‑cell apoptosis and inhibits B‑cell differentiation into antibody-secreting plasma cells, and its presence or absence in mouse models alters the severity of experimental autoimmune encephalomyelitis, immune-mediated hepatitis and diabetes by changing cytokine profiles (IFN‑γ, TNF‑α, IL‑17, IL‑10) and macrophage polarization states. Mechanistically, galectin‑3 influences signaling pathways including MAPK and Wnt/β‑catenin through its effects on receptor organization and intracellular partners, contributing to proliferation and survival in cancer and to fibrogenic and inflammatory signaling in metabolic and cardiovascular disease, although detailed pathway wiring is often tissue- and context-dependent. Clinically, galectin‑3 is frequently upregulated in chronic inflammatory disorders, fibrotic diseases and cancers, and elevated circulating galectin‑3 levels are associated with adverse outcomes in chronic heart failure, chronic kidney disease and cardio‑renal syndrome, leading to its development as a biomarker for early detection and risk stratification and to exploration of galectin‑3 inhibitors for therapeutic modulation of fibrosis and tumor progression. In kidney pathology, galectin‑3 contributes to renal fibrosis and glomerular inflammation, participates in nephrogenesis and regeneration after acute injury, and has been implicated in lupus nephritis, metabolic nephropathies and renal cell carcinoma, where its dual roles in immune modulation, wound repair and fibrogenesis make it both a prognostic marker and a candidate target for intervention.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください